Keitaro Senoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Keitaro Senoo has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
Satoaki Matoba
Department of Cardiac Arrhythmia Research and Innovation, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto 602-8566
21 shared publicationsHirokazu Shiraishi
Affiliation Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
14 shared publicationsArito Yukawa
Affiliation Department of Cardiac Arrhythmia Research and Innovation, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
12 shared publicationsMasahiro Makino
Department of Cardiovascular Medicine, Graduate School of Medical Sciences Kyoto Prefectural University of Medicine Kyoto Japan
11 shared publicationsJun Munakata
Department of Cardiovascular Medicine, Graduate School of Medical Sciences Kyoto Prefectural University of Medicine Kyoto Japan
10 shared publicationsSatoshi Shimoo
Affiliation Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
10 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (5) , e70477
High‐Density Spectral Analysis for Bi‐Atrial Arrhythmogenic Substrate During Non‐Paroxysmal Atrial Fibrillation
Background: Spectral analysis has been utilized to identify localized sites exhibiting high dominant frequency (DF) and high regularity—the critical arrhythmogenic substrate driving atrial fibrillation (AF). This study aimed to elucidate the spectral characteristics of focal activation (FoA) and rotational activation (RoA) sites during AF using a high‐density mapping system. Methods: CARTOFINDER mapping was prospectively performed in both atria of 47 consecutive non‐paroxysmal AF patients using the Octaray catheter prior to ablation. Endocardial unipolar electrograms were exported offline for spectral analysis of DF and the regularity index (RI). Results: CARTOFINDER assessed a total of 48 153 mapping points. Given substantial inter‐subject variability in mean DF, the difference between each point's DF and the subject‐level mean DF was defined as the dominant frequency deviation (DFD). The left atrium (LA) demonstrated significantly higher DFD and RI than the right atrium (both p < 0.001), with the LA roof recording the highest values across all segments. Both FoA and RoA sites exhibited significantly higher DFD and RI compared with sites without FoA and RoA (both p < 0.001). DFD and RI increased progressively with increasing FoA repetitions (both p < 0.001). In contrast, high‐repetition RoA sites (> 16 repetitions) showed a significantly higher RI (0.42 ± 0.13 vs. 0.36 ± 0.12, p < 0.001) but a paradoxically lower DFD (0.14 ± 0.64 Hz vs. 0.26 ± 0.74 Hz, p < 0.001) compared with low‐repetition RoA sites. Conclusions: The combination of CARTOFINDER mapping and spectral analysis may contribute to the mechanistic understanding of non‐paroxysmal AF.
- 21 September 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (5) , e70477
Open AccessHigh‐Density Spectral Analysis for Bi‐Atrial Arrhythmogenic Substrate During Non‐Paroxysmal Atrial Fibrillation
Background: Spectral analysis has been utilized to identify localized sites exhibiting high dominant frequency (DF) and high regularity—the critical arrhythmogenic substrate driving atrial fibrillation (AF). This study aimed to elucidate the spectral characteristics of focal activation (FoA) and rotational activation (RoA) sites during AF using a high‐density mapping system. Methods: CARTOFINDER mapping was prospectively performed in both atria of 47 consecutive non‐paroxysmal AF patients using the Octaray catheter prior to ablation. Endocardial unipolar electrograms were exported offline for spectral analysis of DF and the regularity index (RI). Results: CARTOFINDER assessed a total of 48 153 mapping points. Given substantial inter‐subject variability in mean DF, the difference between each point's DF and the subject‐level mean DF was defined as the dominant frequency deviation (DFD). The left atrium (LA) demonstrated significantly higher DFD and RI than the right atrium (both p < 0.001), with the LA roof recording the highest values across all segments. Both FoA and RoA sites exhibited significantly higher DFD and RI compared with sites without FoA and RoA (both p < 0.001). DFD and RI increased progressively with increasing FoA repetitions (both p < 0.001). In contrast, high‐repetition RoA sites (> 16 repetitions) showed a significantly higher RI (0.42 ± 0.13 vs. 0.36 ± 0.12, p < 0.001) but a paradoxically lower DFD (0.14 ± 0.64 Hz vs. 0.26 ± 0.74 Hz, p < 0.001) compared with low‐repetition RoA sites. Conclusions: The combination of CARTOFINDER mapping and spectral analysis may contribute to the mechanistic understanding of non‐paroxysmal AF.
- Open Access
- 17 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0353867
Rates and predictors of hospital visits after “Possible AF” alerts from a home ECG monitor in older adults with hypertension: A sub-analysis of the Omron Heart Study
Background: Home ECG can detect atrial fibrillation (AF), but patients’ hospital visit behavior after “possible AF” alerts remains uncertain. We assessed the rates, timing, and correlates of hospital visits following “possible AF” alerts in older adults with hypertension. Methods and findings: In a nationwide, decentralized cohort in Japan, 4,078 individuals aged ≥60 years enrolled; 3,820 were analyzed after exclusions. Participants used a home BP monitor equipped with a 30-s single-lead ECG capable of detecting “possible AF”, twice daily for 3 months. Of 1,700 participants who received ≥1 “possible AF” alert, 399 (23.5%) reported an alert-prompted healthcare facility visit within 3 months, and 289 (17.0%) underwent additional testing. Among 175 participants with valid visit dates, the median time to visit was 28 days (mean 36.4). In multivariable models, factors associated with lower odds of a hospital visit included age < 65 years (OR 0.75, 95% CI 0.59–0.95, p = 0.016), current drinking (OR 0.73, 0.57–0.95, p = 0.018), no daily palpitations (OR 0.69, 0.50–0.95, p = 0.022), and no palpitations on the alert day (OR 0.51, 0.30–0.85, p = 0.010). Notably, 105 of 220 (47.7%) participants with physician-adjudicated AF remained without a clinical diagnosis at 12 months. Conclusions: In this cohort of older, hypertensive individuals, follow-up rates after a “possible AF” alert were low; fewer than one in four individuals visited a healthcare facility, and fewer than one in five underwent additional testing within 3 months. Hospital visits were less common among younger participants, those who consume alcohol, and those without palpitations. These findings highlight significant gaps between mHealth alerts and subsequent clinical action.
- 17 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0353867
Open AccessRates and predictors of hospital visits after “Possible AF” alerts from a home ECG monitor in older adults with hypertension: A sub-analysis of the Omron Heart Study
Background: Home ECG can detect atrial fibrillation (AF), but patients’ hospital visit behavior after “possible AF” alerts remains uncertain. We assessed the rates, timing, and correlates of hospital visits following “possible AF” alerts in older adults with hypertension. Methods and findings: In a nationwide, decentralized cohort in Japan, 4,078 individuals aged ≥60 years enrolled; 3,820 were analyzed after exclusions. Participants used a home BP monitor equipped with a 30-s single-lead ECG capable of detecting “possible AF”, twice daily for 3 months. Of 1,700 participants who received ≥1 “possible AF” alert, 399 (23.5%) reported an alert-prompted healthcare facility visit within 3 months, and 289 (17.0%) underwent additional testing. Among 175 participants with valid visit dates, the median time to visit was 28 days (mean 36.4). In multivariable models, factors associated with lower odds of a hospital visit included age < 65 years (OR 0.75, 95% CI 0.59–0.95, p = 0.016), current drinking (OR 0.73, 0.57–0.95, p = 0.018), no daily palpitations (OR 0.69, 0.50–0.95, p = 0.022), and no palpitations on the alert day (OR 0.51, 0.30–0.85, p = 0.010). Notably, 105 of 220 (47.7%) participants with physician-adjudicated AF remained without a clinical diagnosis at 12 months. Conclusions: In this cohort of older, hypertensive individuals, follow-up rates after a “possible AF” alert were low; fewer than one in four individuals visited a healthcare facility, and fewer than one in five underwent additional testing within 3 months. Hospital visits were less common among younger participants, those who consume alcohol, and those without palpitations. These findings highlight significant gaps between mHealth alerts and subsequent clinical action.
- Open Access
- 6 January 2026
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 6 (1)
Association between depression and risk of ischaemic stroke in patients with atrial fibrillation
Aims: Atrial fibrillation (AF) is a major cause of ischaemic stroke (IS), and its risk is assessed using existing risk stratification scores. However, the impact of psychiatric comorbidities such as depression on this risk has not been sufficiently considered. Depression is commonly observed in individuals with AF and is increasingly recognized as an independent risk factor for IS. This study aimed to examine the association between depression and the risk of IS in AF. Methods and results: A cohort study of individuals with AF was conducted using a large Japanese healthcare database. Hazard ratios (HR) for IS in patients with depression were estimated using a multivariable Cox proportional hazards model, adjusting for established cardiovascular risk factors and medication use (e.g. anticoagulant therapy). Additional analyses included age- and sex-stratified analyses, time-dependent models, and sensitivity analyses to assess reverse causality bias. A total of 22 939 individuals with AF were included in the analysis. Among them, 1774 patients (7.7%) had a diagnosis of depression at baseline. During follow-up, IS occurred at a higher rate in individuals with depression. Multivariate analysis demonstrated that depression was an independent and significant predictor for IS (HR 1.39, 95% confidence interval 1.16–1.66, P < 0.001). Stratified analysis by age revealed this association was particularly pronounced in younger individuals. Conclusion: This study demonstrates that depression in individuals with AF is a predictor of IS, independent of established cardiovascular risk factors. These findings highlight the potential importance of screening for depression as part of the holistic risk assessment for patients with AF.
- 6 January 2026
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 6 (1)
Open AccessAssociation between depression and risk of ischaemic stroke in patients with atrial fibrillation
Aims: Atrial fibrillation (AF) is a major cause of ischaemic stroke (IS), and its risk is assessed using existing risk stratification scores. However, the impact of psychiatric comorbidities such as depression on this risk has not been sufficiently considered. Depression is commonly observed in individuals with AF and is increasingly recognized as an independent risk factor for IS. This study aimed to examine the association between depression and the risk of IS in AF. Methods and results: A cohort study of individuals with AF was conducted using a large Japanese healthcare database. Hazard ratios (HR) for IS in patients with depression were estimated using a multivariable Cox proportional hazards model, adjusting for established cardiovascular risk factors and medication use (e.g. anticoagulant therapy). Additional analyses included age- and sex-stratified analyses, time-dependent models, and sensitivity analyses to assess reverse causality bias. A total of 22 939 individuals with AF were included in the analysis. Among them, 1774 patients (7.7%) had a diagnosis of depression at baseline. During follow-up, IS occurred at a higher rate in individuals with depression. Multivariate analysis demonstrated that depression was an independent and significant predictor for IS (HR 1.39, 95% confidence interval 1.16–1.66, P < 0.001). Stratified analysis by age revealed this association was particularly pronounced in younger individuals. Conclusion: This study demonstrates that depression in individuals with AF is a predictor of IS, independent of established cardiovascular risk factors. These findings highlight the potential importance of screening for depression as part of the holistic risk assessment for patients with AF.
- Open Access
- 29 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Evaluating the appropriateness and safety of generative AI in delivering lifestyle guidance for atrial fibrillation patients
Lifestyle factors play a major role in atrial fibrillation (AF) incidence, but the effectiveness of lifestyle counseling varies among individuals. Due to limited consultation time, physicians often provide only brief guidance, leaving patients to manage changes on their own. This study assessed the clinical utility of three Large Language Models (LLMs) for delivering accurate and personalized lifestyle guidance: (1) GPT-4o, (2) a retrieval-augmented model using a curated Q&A database (DB GPT), and (3) a modular RAG model retrieving evidence from PubMed (PubMed GPT). Sixty-six questions from 16 AF patients were categorized into exercise, diet, lifestyle, and other domains. Five experienced electrophysiologists independently evaluated LLM-generated lifestyle guidance and physician-provided counseling responses using ten dimensions. GPT-4o demonstrated a comparable level of scientific consensus to electrophysiologists, while achieving a lower error rate and significantly higher levels of specialized content, empathy, and helpfulness. DB GPT and PubMed GPT showed similar error rates, proportions of specialized content, empathy, and helpfulness compared to electrophysiologists, but exhibited strengths in specialized content in exercise-related and accuracy in diet-related dimensions. These findings suggest that integrating complementary model strengths may help develop safer and more reliable medical AI systems.
- 29 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessEvaluating the appropriateness and safety of generative AI in delivering lifestyle guidance for atrial fibrillation patients
Lifestyle factors play a major role in atrial fibrillation (AF) incidence, but the effectiveness of lifestyle counseling varies among individuals. Due to limited consultation time, physicians often provide only brief guidance, leaving patients to manage changes on their own. This study assessed the clinical utility of three Large Language Models (LLMs) for delivering accurate and personalized lifestyle guidance: (1) GPT-4o, (2) a retrieval-augmented model using a curated Q&A database (DB GPT), and (3) a modular RAG model retrieving evidence from PubMed (PubMed GPT). Sixty-six questions from 16 AF patients were categorized into exercise, diet, lifestyle, and other domains. Five experienced electrophysiologists independently evaluated LLM-generated lifestyle guidance and physician-provided counseling responses using ten dimensions. GPT-4o demonstrated a comparable level of scientific consensus to electrophysiologists, while achieving a lower error rate and significantly higher levels of specialized content, empathy, and helpfulness. DB GPT and PubMed GPT showed similar error rates, proportions of specialized content, empathy, and helpfulness compared to electrophysiologists, but exhibited strengths in specialized content in exercise-related and accuracy in diet-related dimensions. These findings suggest that integrating complementary model strengths may help develop safer and more reliable medical AI systems.
- Open Access
- 25 December 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 7 (3) , 630-632
12-lead electrocardiogram-based artificial intelligence model accurately predicts near-term atrial fibrillation in patients with embolic stroke of undetermined source
- 25 December 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 7 (3) , 630-632
Open Access12-lead electrocardiogram-based artificial intelligence model accurately predicts near-term atrial fibrillation in patients with embolic stroke of undetermined source
- Open Access
- 19 November 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (37) , 105744
Takotsubo Syndrome Following Pulmonary Vein Isolation With Pulse Field Ablation
- 19 November 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (37) , 105744
Open AccessTakotsubo Syndrome Following Pulmonary Vein Isolation With Pulse Field Ablation
- 21 October 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
Atrial Fibrillation Screening: Burden or Benefit for Patients and the Healthcare System
Atrial fibrillation (AF) is the most common sustained arrhythmia and raises ischemic stroke risk fivefold, even when asymptomatic. Early detection and timely initiation of oral anticoagulation can significantly reduce stroke incidence, motivating interest in population‐level AF screening. This review synthesizes findings from large‐scale trials and digital health studies, including wearable device—based detection, and highlights both benefits and limitations of screening. Benefits include earlier diagnosis of silent AF, timely treatment, and potential reductions in stroke burden. However, drawbacks such as false positives, inconclusive results, unnecessary follow‐up testing, patient anxiety, and resource strain remain important concerns. Emerging strategies—such as AI‐guided risk stratification, improved signal processing, and integrated digital care pathways—offer promise in improving diagnostic accuracy, reducing false alarms, and streamlining clinical management. When implemented through targeted, technology‐enhanced approaches, AF screening has the potential to benefit patients and healthcare systems by preventing strokes and optimizing resource use. However, its overall value depends on balancing improved detection and clinical outcomes against the risks of overdiagnosis, psychological burden, and system costs. Ultimately, the success of AF screening will require careful integration of novel technologies with evidence‐based care pathways to ensure clinically meaningful and sustainable healthcare impact.
- 21 October 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
Atrial Fibrillation Screening: Burden or Benefit for Patients and the Healthcare System
Atrial fibrillation (AF) is the most common sustained arrhythmia and raises ischemic stroke risk fivefold, even when asymptomatic. Early detection and timely initiation of oral anticoagulation can significantly reduce stroke incidence, motivating interest in population‐level AF screening. This review synthesizes findings from large‐scale trials and digital health studies, including wearable device—based detection, and highlights both benefits and limitations of screening. Benefits include earlier diagnosis of silent AF, timely treatment, and potential reductions in stroke burden. However, drawbacks such as false positives, inconclusive results, unnecessary follow‐up testing, patient anxiety, and resource strain remain important concerns. Emerging strategies—such as AI‐guided risk stratification, improved signal processing, and integrated digital care pathways—offer promise in improving diagnostic accuracy, reducing false alarms, and streamlining clinical management. When implemented through targeted, technology‐enhanced approaches, AF screening has the potential to benefit patients and healthcare systems by preventing strokes and optimizing resource use. However, its overall value depends on balancing improved detection and clinical outcomes against the risks of overdiagnosis, psychological burden, and system costs. Ultimately, the success of AF screening will require careful integration of novel technologies with evidence‐based care pathways to ensure clinically meaningful and sustainable healthcare impact.
- Open Access
- 8 August 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 6 (11) , 1853-1855
Daily home ECG monitoring for assessing the blanking period after catheter ablation in persistent atrial fibrillation
- 8 August 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 6 (11) , 1853-1855
Open AccessDaily home ECG monitoring for assessing the blanking period after catheter ablation in persistent atrial fibrillation
- Open Access
- 16 July 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (4) , e70143
Advancing Atrial Fibrillation Screening—Clinical Utility and Future Directions of Smartwatch ECG
- 16 July 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (4) , e70143
Open AccessAdvancing Atrial Fibrillation Screening—Clinical Utility and Future Directions of Smartwatch ECG
- Open Access
- 13 February 2025
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 12 (1) , e65923
An Explainable AI Application (AF’fective) to Support Monitoring of Patients With Atrial Fibrillation After Catheter Ablation: Qualitative Focus Group, Design Session, and Interview Study
Background: The opaque nature of artificial intelligence (AI) algorithms has led to distrust in medical contexts, particularly in the treatment and monitoring of atrial fibrillation. Although previous studies in explainable AI have demonstrated potential to address this issue, they often focus solely on electrocardiography graphs and lack real-world field insights. Objective: We addressed this gap by incorporating standardized clinical interpretation of electrocardiography graphs into the system and collaborating with cardiologists to co-design and evaluate this approach using real-world patient cases and data. Methods: We conducted a 3-stage iterative design process with 23 cardiologists to co-design, evaluate, and pilot an explainable AI application. In the first stage, we identified 4 physician personas and 7 explainability strategies, which were reviewed in the second stage. A total of 4 strategies were deemed highly effective and feasible for pilot deployment. On the basis of these strategies, we developed a progressive web application and tested it with cardiologists in the third stage. Results: The final progressive web application prototype received above-average user experience evaluations and effectively motivated physicians to adopt it owing to its ease of use, reliable information, and explainable functionality. In addition, we gathered in-depth field insights from cardiologists who used the system in clinical contexts. Conclusions: Our study identified effective explainability strategies, emphasized the importance of curating actionable features and setting accurate expectations, and suggested that many of these insights could apply to other disease care contexts, paving the way for future real-world clinical evaluations.
- 13 February 2025
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 12 (1) , e65923
Open AccessAn Explainable AI Application (AF’fective) to Support Monitoring of Patients With Atrial Fibrillation After Catheter Ablation: Qualitative Focus Group, Design Session, and Interview Study
Background: The opaque nature of artificial intelligence (AI) algorithms has led to distrust in medical contexts, particularly in the treatment and monitoring of atrial fibrillation. Although previous studies in explainable AI have demonstrated potential to address this issue, they often focus solely on electrocardiography graphs and lack real-world field insights. Objective: We addressed this gap by incorporating standardized clinical interpretation of electrocardiography graphs into the system and collaborating with cardiologists to co-design and evaluate this approach using real-world patient cases and data. Methods: We conducted a 3-stage iterative design process with 23 cardiologists to co-design, evaluate, and pilot an explainable AI application. In the first stage, we identified 4 physician personas and 7 explainability strategies, which were reviewed in the second stage. A total of 4 strategies were deemed highly effective and feasible for pilot deployment. On the basis of these strategies, we developed a progressive web application and tested it with cardiologists in the third stage. Results: The final progressive web application prototype received above-average user experience evaluations and effectively motivated physicians to adopt it owing to its ease of use, reliable information, and explainable functionality. In addition, we gathered in-depth field insights from cardiologists who used the system in clinical contexts. Conclusions: Our study identified effective explainability strategies, emphasized the importance of curating actionable features and setting accurate expectations, and suggested that many of these insights could apply to other disease care contexts, paving the way for future real-world clinical evaluations.